within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonSteroids.M01AA02_Mofebutazone;

model Mofebutazone
  extends Pharmacolibrary.Drugs.ATC.M.M01AA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M01AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mofebutazone is a nonsteroidal anti-inflammatory drug (NSAID) that was historically used for the treatment of inflammation, pain, and rheumatic disorders such as arthritis. Due to safety concerns, including hematological side effects and availability of safer alternatives, mofebutazone is rarely used and is not approved in many countries today.</p><h4>Pharmacokinetics</h4><p>No published population pharmacokinetic model available for mofebutazone in humans. The following parameters are estimated based on analogy to similar NSAIDs and historical pharmacology reviews. Estimates likely reflect typical oral administration in adult patients.</p><h4>References</h4><ol><li><p>Kassem, MA, &amp; Schulte, KE (1984). Pharmacokinetics of [4-14C] mofebutazone after oral administration in man. <i>European journal of drug metabolism and pharmacokinetics</i> 9(3) 223–227. DOI:<a href=&quot;https://doi.org/10.1007/BF03189645&quot;>10.1007/BF03189645</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6519123/&quot;>https://pubmed.ncbi.nlm.nih.gov/6519123</a></p></li><li><p>Bass, VM, et al., &amp; Schulte, KE (1980). Disposition of [4-14C]mofebutazone in the rat. <i>European journal of drug metabolism and pharmacokinetics</i> 5(4) 201–206. DOI:<a href=&quot;https://doi.org/10.1007/BF03189465&quot;>10.1007/BF03189465</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7250143/&quot;>https://pubmed.ncbi.nlm.nih.gov/7250143</a></p></li><li><p>Nielsen-Kudsk, F (1980). HPLC-determination of some antiinflammatory, weak analgesic and uricosuric drugs in human blood plasma and its application to pharmacokinetics. <i>Acta pharmacologica et toxicologica</i> 47(4) 267–273. DOI:<a href=&quot;https://doi.org/10.1111/j.1600-0773.1980.tb03653.x&quot;>10.1111/j.1600-0773.1980.tb03653.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6970498/&quot;>https://pubmed.ncbi.nlm.nih.gov/6970498</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Mofebutazone;
